Evidence map›Paper›PMID 41747240›Full record

ArticleJMIR formative research2026

Using AI in Forward-Backward Translation of Questionnaires for Men Invited to Prostate Cancer Screening: Methodological Study.

Sofie Meyer Andersen, Pia Kirkegaard, Krzysztof Tupikowski, Katarzyna Hodyra-Stefaniak, Mette Bach Larsen, PRAISE-U Consortium

Abstract read
In one paragraph

Article in JMIR formative research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sofie Meyer AndersenDepartment of Clinical Medicine, Faculty of Health, Aarhus University, Aarhus N, Denmark.ORCID https://orcid.org/0009-0004-3328-895X
Pia KirkegaardDepartment of Clinical Medicine, Faculty of Health, Aarhus University, Aarhus N, Denmark.ORCID https://orcid.org/0000-0003-2099-253X
Krzysztof TupikowskiSubdivision of Urology, Lower Silesian Center for Oncology, Pulmonology and Hematology, Wrocław, Poland.ORCID https://orcid.org/0000-0002-0958-7587
Katarzyna Hodyra-StefaniakResearch and Development Department, Lower Silesian Center for Oncology, Pulmonology and Hematology, Wrocław, Poland.ORCID https://orcid.org/0000-0003-4758-566X
Mette Bach LarsenDepartment of Oncology, Lillebaelt Hospital, Vejle, Denmark.ORCID https://orcid.org/0000-0002-0727-5571
PRAISE-U ConsortiumSee Acknowledgments, .

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTranslation is important in research to ensure cultural relevance, accuracy, and generalizability, particularly in cross-cultural studies. The forward-backward translation method of the World Health Organization (WHO) is commonly used to improve linguistic and conceptual accuracy but is often time-consuming and resource intensive. The development of advanced artificial intelligence (AI) offers new opportunities to make the translation process more efficient, potentially reducing time and costs. However, concerns remain regarding the ability of AI to capture cultural nuances and complex linguistic structures, which may affect translation quality. Therefore, evidence on how AI can be effectively integrated into established translation frameworks remains limited.

objectiveThis study aimed to explore the use of AI in the forward-backward translation process for questionnaires.

methodsWe used an adapted version of the WHO 4-step forward-backward translation method to translate the questionnaires from English into Polish. The questionnaires included the Prostate Cancer Screening Education (PROCASE) Knowledge Index, the Attitude Scale, Risk Perception items, and the Brief Health Literacy Scale for Adults. First, 2 AI tools (ChatGPT [GPT-3.5] and Microsoft Bing Copilot) were used for translating from English to Polish. Second, 2 native Polish speakers focused on content understanding independently reviewed and corrected the AI-generated Polish version and agreed on a new version. Third, the AI-generated Polish translation was back-translated from Polish into English using the same AI tools. Any discrepancies were discussed by an expert panel consisting of native speakers of English and Polish. This procedure ensured linguistic accuracy and conceptual similarity. Finally, 3 individual cognitive interviews were conducted with native Polish-speaking men to identify whether the questionnaires measured the intended constructs and to find any issues that the respondents might encounter during the response process.

resultsMinor discrepancies between the two AI-generated Polish phrases "umiera z innej przyczyny" and "umiera z powodu innych przyczyn" were merged by native Polish speakers in the PROCASE Knowledge Index. The original questionnaires and the AI-generated questionnaires had minor differences, but they did not affect the meaning of the questions or what was being asked. We conducted individual cognitive interviews (n=3) with participants aged 47 to 74 years. After the interviews, the questionnaires were adjusted with a few changes to make them easier to understand. In the Attitude Scale, the AI-generated Polish translation was changed from "nieco" to "trochę" to align with everyday language and improve understanding.

conclusionsAI can be an effective tool in the translation process, offering time and resource savings while maintaining accuracy. However, human involvement is still needed to optimize translation.

Indexed as

Artificial IntelligenceEarly Detection of CancerProstatic NeoplasmsAgedHumansMaleMiddle AgedPolandPsychometricsSurveys and QuestionnairesTranslatingTranslationsAIartificial intelligencecognitive interviewscross-cultural researchforward-backward translationhealth survey translationprostate cancer screeningquestionnaire adaptation

Identifiers

PMID41747240
PMCPMC12982947

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.